Stochastic pharmacodynamics of a heterogeneous tumour-cell population

Standard pharmacodynamic models are ordinary differential equations without the features of stochasticity and heterogeneity. We develop and analyse a stochastic model of a heterogeneous tumour-cell population treated with a drug, where each cell has a different value of an attribute linked to survival. Once the drug reduces a cell's value below a threshold, the cell is susceptible to death. The elimination of the last cell in the population is a natural endpoint that is not available in deterministic models. We find formulae for the probability density of this extinction time in a collection of tumour cells, each with a different regulator value, under the influence of a drug. There is a logarithmic relationship between tumour population size and mean time to extinction. We also analyse the population under repeated drug doses and subsequent recoveries. Stochastic cell death and division events (and the relevant mechanistic parameters) determine the ultimate fate of the cell population. We identify the critical division rate separating long-term tumour population growth from successful multiple-dose treatment.

Authors

Institutions

Publication Details

Journal
Journal of Pharmacokinetics and Pharmacodynamics
Published
2025-05-05
DOI
https://doi.org/10.1007/s10928-025-09974-7
Primary Topic
Mathematical Biology Tumor Growth
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Stochastic pharmacodynamics of a heterogeneous tumour-cell population

Grant Lythe, Van Thuy Truong, Vincent F. S. Dubois, James Yates et al.
Journal of Pharmacokinetics and Pharmacodynamics
Mathematical Biology Tumor Growth
article

Stochastic pharmacodynamics of a heterogeneous tumour-cell population

Grant Lythe, Van Thuy Truong, Vincent F. S. Dubois, James Yates, Paolo Vicini
article en

Abstract

Standard pharmacodynamic models are ordinary differential equations without the features of stochasticity and heterogeneity. We develop and analyse a stochastic model of a heterogeneous tumour-cell population treated with a drug, where each cell has a different value of an attribute linked to survival. Once the drug reduces a cell's value below a threshold, the cell is susceptible to death. The elimination of the last cell in the population is a natural endpoint that is not available in deterministic models. We find formulae for the probability density of this extinction time in a collection of tumour cells, each with a different regulator value, under the influence of a drug. There is a logarithmic relationship between tumour population size and mean time to extinction. We also analyse the population under repeated drug doses and subsequent recoveries. Stochastic cell death and division events (and the relevant mechanistic parameters) determine the ultimate fate of the cell population. We identify the critical division rate separating long-term tumour population growth from successful multiple-dose treatment.

Journal of Pharmacokinetics and PharmacodynamicsVol. 52(3)
Ablynx (Belgium) (BE), University of Leeds (GB), Age UK (GB), AstraZeneca (Australia) (AU)
European Commission, Horizon 2020 Framework Programme
Good health and well-being
Openalex Percentile: Top 89%
Mathematical Biology Tumor Growth
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Stochastic pharmacodynamics of a heterogeneous tumour-cell population — Grant Lythe, Van Thuy Truong, et al. · Journal of Pharmacokinetics and Pharmacodynamics (2025) | TGRS Research Map | TGRS